SiPhox
Company

Last deal

$17M

Amount

Series A

Stage

19.07.2023

Date

6

all rounds

$48.5M

Total amount

General

About Company
SiPhox offers a handheld optical chip-based medical diagnostics platform.

Industry

Sector :

Subsector :

Keywords :

founded date

19.02.2020

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

SiPhox has developed a compact testing device that enables point-of-care and At-Home medical testing. Their kit utilizes a silicon photonic chip, which combines RNA, antibody, and antigen tests, allowing for safe and disposable disease testing. Founded by Diedrik Vermeulen and Michael Dubrovsky in 2020, SiPhox aims to create a handheld biosensing platform that integrates multiple laboratory instruments into a single device. With each cartridge costing only $0.50, their technology offers highly sensitive readouts for immunoassays and RNA/DNA testing. Leveraging their expertise in optical chip technology, SiPhox is revolutionizing the field of integrated photonics in the realm of biology.
Contacts

Social url